Irsolgladin Maleate Tablet 2 Milligrams

Adult dose

1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1∼2 divided doses daily.

This medicine contains lactose, so it should not be used in patients with genetic issues that prevent the breakdown of lactose. Using this medicine may cause side effects such as liver dysfunction, constipation, rash, itching, and diarrhea. Regular tests may be necessary as liver function test values may increase. Symptoms such as dizziness, drowsiness, abdominal bloating, and decreased appetite may rarely occur, so caution is advised. Elderly patients should start with a lower dose and carefully monitor their condition due to potentially weakened bodily functions. Women who are pregnant or may become pregnant should only use this medicine if its benefits outweigh the risks, as its safety has not been fully established. Breastfeeding women should avoid this medicine as it may be partially transmitted through breast milk; if unavoidable, it is recommended to discontinue breastfeeding. The safety of this medicine in children has not been sufficiently confirmed, so it should be used cautiously in children. This medicine should be stored out of reach of children and transferring it to another container may pose a risk of accidents and quality deterioration, so caution is advised.

• Abnormal liver function
• elevated ALT (GPT)
• elevated AST (GOT)
• constipation
• rash
• itching
• diarrhea
• elevated ALP
• nausea
• vomiting

This medicine may be sensitive to air or humidity, so it should be stored in a tightly sealed container. The storage temperature should ideally be maintained between 1 and 30 degrees Celsius.

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle